Oil Jumps To $66 On Signs Of Rising Crude Demand
The international oil benchmark, Brent crude, surged by five per cent on Wednesday, after a report from the International Energy Agency, followed by US inventory data, boosted optimism about returning demand after the coronavirus lockdowns last year crushed fuel consumption.
Brent, against which Nigeria’s oil is priced, rose by $3.06 to $66.73 per barrel by
US crude inventories fell by 5.9 million barrels last week, the Energy Information Administration said, exceeding analysts’ forecasts for a 2.9 million-barrel drop. East Coast crude stocks hit a record low, Reuters reported on Wednesday.
Petrol supplied in latest week, indicating the US consumption of the fuel, rose to 8.9 million barrels per day, the highest since August, the EIA report showed.
Petrol stocks edged higher by 309,000 barrels, less than expectations for a 786,000-barrel rise. Distillate stockpiles fell by 2.1 million barrels in the week, versus expectations for a 971,000-barrel rise.
“All in all, it was a very supportive report. It really looks like we’re getting a return to some more solid demand numbers and that should keep us going,” Phil Flynn, senior analyst at Price Futures Group in Chicago, was quoted as saying.
Earlier in the session, oil prices rose on a report from the IEA that predicted global oil demand and supply were set to rebalance in the second half of the year.
It added that producers may then need to pump an additional two million bpd to meet the expected demand.
“That IEA report is one of the best ones we’ve seen them publish in a while in terms of being optimistic about the continued rebound in demand,” said John Kilduff, partner at Again Capital in New York.
Similarly, the Organisation of the Petroleum Exporting Countries on Tuesday raised its global demand forecast by 70,000 bpd from last month’s forecast and now expects global demand to rise by 5.95 million bpd in 2021.
Signs of a strong economic recovery in China and the United States have underpinned recent price gains, but stalled vaccine rollouts worldwide and soaring COVID-19 cases in India and Brazil have slowed the market’s advance.